Being More Realistic about the Public Health Impact of Genomic Medicine

1. CollinsFS

1999 Shattuck lecture—medical and societal consequences of the Human Genome Project. N Engl J Med 341 28 37

2. van OmmenGJ

BakkerE

den DunnenJT

1999 The human genome project and the future of diagnostics, treatment, and prevention. Lancet 354 Suppl 1 SI5 10

3. DonnellyP

2008 Progress and challenges in genome-wide association studies in humans. Nature 456 728 31

4. HindorffLA

SethupathyP

JunkinsHA

RamosEM

MehtaJP

2009 Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A 106 9362 7

5. ManolioTA

BrooksLD

CollinsFS

2008 A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118 1590 605

6. ManolioTA

CollinsFS

CoxNJ

GoldsteinDB

HindorffLA

2009 Finding the missing heritability of complex diseases. Nature 461 747 53

7. GulcherJ

StefanssonK

2010 Genetic risk information for common diseases may indeed be already useful for prevention and early detection. Eur J Clin Invest 40 56 63

8. KhouryMJ

2003 Genetics and genomics in practice: the continuum from genetic disease to genetic information in health and disease. Genet Med 5 261 268

9. KhouryMJ

YangQ

GwinnM

LittleJ

FlandersWD

2004 An epidemiological assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genet Med 6 38 47

10. KraftP

HunterDJ

2009 Genetic risk prediction—are we there yet? N Engl J Med 360 1701 3

11. PharoahPD

AntoniouA

BobrowM

ZimmernRL

EastonDF

2002 Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31 33 6

12. VisscherPM

2008 Sizing up human height variation. Nat Genet 40 489 490

13. ClaytonDG

2009 Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet 5 e1000540 doi:10.1371/journal.pgen.1000540

14. JanssensAC

AulchenkoYS

ElefanteS

BorsboomGJ

SteyerbergEW

2006 Predictive testing for complex diseases using multiple genes: fact or fiction? Genet Med 8 395 400

15. WrayNR

GoddardME

VisscherPM

2007 Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res 17 1520 8

16. WrayNR

YangJ

GoddardME

VisscherPM

2010 The genetic interpretation of area under the ROC curve in genomic profiling. PLoS Genet 6 e1000864 doi:10.1371/journal.pgen.1000864

17. JanssensAC

van DuijnCM

2009 Genome-based prediction of common diseases: methodological considerations for future research. Genome Med 1 20

18. LangoH

PalmerCN

MorrisAD

ZegginiE

HattersleyAT

2008 Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 57 3129 35

19. KathiresanS

MelanderO

AnevskiD

GuiducciC

BurttNP

2008 Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 358 1240 1249

20. Van der NetJB

JanssensACJW

SijbrandsEJG

SteyerbergEW

2009 Value of genetic profiling for the prediction of coronary heart disease. Am Heart J 158 105 110

21. PharoahPD

AntoniouAC

EastonDF

PonderBA

2008 Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 358 2796 803

22. VisscherPM

HillWG

WrayNR

2008 Heritability in the genomics era—concepts and misconceptions. Nat Rev Genet 9 255 66

23. EvansJP

SkrzyniaC

BurkeW

2001 The complexities of predictive genetic testing. BMJ 322 1052 6

24. KhouryMJ

McCabeLL

McCabeER

2003 Population screening in the age of genomic medicine. N Engl J Med 348 50 8

25. RoseG

1992 The strategy of preventive medicine Oxford Oxford University Press

26. HagaSB

KhouryMJ

BurkeW

2003 Genomic profiling to promote a healthy lifestyle: not ready for prime time. Nat Genet 34 347 50

27. RansohoffDF

KhouryMJ

2010 Personal genomics: information can be harmful. Eur J Clin Invest 40 64 8

28. FiorentinoM

CapizziE

LodaM

2010 Blood and tissue biomarkers in prostate cancer: state of the art. Urol Clin North Am 37 131 41

29. BarrattAL

StocklerMR

2009 Screening for prostate cancer: explaining new trial results and their implications to patients. Med J Aust 191 226 9

30. HunterDJ

KhouryMJ

DrazenJM

2008 Letting the genome out of the bottle—will we get our wish? N Engl J Med 358 105 7

31. PetoJ

2001 Cancer epidemiology in the last century and the next decade. Nature 411 390 295

32. GreenRC

RobertsJS

CupplesLA

RelkinNR

WhitehousePJ

2009 Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 361 245 54

33. CameronLD

ShermanKA

MarteauTM

BrownPM

2009 Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychol 28 307 16

34. McBrideCM

BowenD

BrodyLC

ConditCM

CroyleRT

2010 Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med 38 556 65

35. SeniorV

MarteauTM

WeinmanJ

2000 Impact of genetic testing on causal models of heart disease and arthritis: an analogue study. Psychol Health 14 1077 1088

36. WrightAJ

WeinmanJ

MarteauTM

2003 The impact of learning of a genetic predisposition to nicotine dependence: an analogue study. Tob Control 12 227 30

37. MarteauTM

WeinmanJ

2006 Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med 62 1360 1368

38. ChapmanS

MacKenzieR

2010 The global research neglect of unassisted smoking cessation: causes and consequences. PLoS Med 7 e1000216 doi:10.1371/journal.pmed.1000216

39. McBrideCM

BeplerG

LipkusIM

LynaP

SamsaG

2002 Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev 11 521 528

40. SandersonSC

HumphriesSE

HubbartC

2008 Psychological and behavioural impact of genetic testing smokers for lung cancer risk: a phase II exploratory trial. J Health Psychol 13 481 494

41. WatsonM

FosterC

EelesR

EcclesD

AshleyS

2004 Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort. Br J Cancer 91 1787 1794

42. WhiteV

HillD

SiahpushM

BobevskiI

2003 How has the prevalence of cigarette smoking changed among Australian adults? Trends in smoking prevalence between 1980 and 2001. Tob Control 12 (Suppl 2_ ii67 74

43. PierceJP

GilpinEA

EmerySL

WhiteMM

RosbrookB

1998 Has the California tobacco control program reduced smoking? JAMA 280 893 899

44. HallWD

MaddenP

LynskeyM

2002 The genetics of tobacco use: methods, findings and policy implications. Tob Control 11 119 124

45. ChaloupkaFJ

2010 Beyond tax: the need for research on alcohol pricing policies. Addiction 105 397 8

46. KruegerH

WilliamsD

KaminskyB

McLeanD

2007 The health impact of smoking and obesity and what to do about it Toronto University of Toronto Press

47. HallWD

GartnerCE

CarterA

2008 The genetics of nicotine addiction liability: ethical and social policy implications. Addiction 103 350 359

48. GundleKR

DingelMJ

KoenigBA

2010 ‘To prove this is the industry's best hope’: big tobacco's support of research on the genetics of nicotine addiction. Addiction 105 974 983

49. HallWD

2005 British drinking: a suitable case for treatment? BMJ 331 527 528

50. BaborT

MillerP

EdwardsG

2010 Vested interests, addiction research and public policy. Addiction 105 4 5

51. VreckoS

2008 Capital ventures into biology: biosocial dynamics in the industry and science of gambling. Econ Soc 37 50 67

52. Davey SmithG

EbrahimS

LewisS

HansellAL

PalmerLJ

2005 Genetic epidemiology and public health: hope, hype, and future prospects. Lancet 366 1484 98